[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [PeptiDream Inc.](/topic/$4587t) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "We started the development of 64Cu-PSMA-I&T for advanced prostate cancer as part of a registrational trial in Japan. In parallel we are also planning to start a clinical trial for its therapeutic pair 117Lu-PSMA-I&T. Press" [X Link](https://x.com/PeptidreamInc/status/1980128743059529796) [@PeptidreamInc](/creator/x/PeptidreamInc) 2025-10-20T04:27Z XX followers, XX engagements "Ever wondered how much it costs to create a new drug Spoiler alert: its not chump change Dive into the world of peptide drug discovery and see how companies like PeptiDream are gearing up to challenge mega-pharmas globally. Check it out" [X Link](https://x.com/pe65oni/status/1979072978546483584) [@pe65oni](/creator/x/pe65oni) 2025-10-17T06:32Z XXX followers, XX engagements "PeptiDream PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan #biotech #news" [X Link](https://x.com/BCBionetwork/status/1978488560454861133) [@BCBionetwork](/creator/x/BCBionetwork) 2025-10-15T15:50Z 1481 followers, XX engagements "🎯 Presentations from PeptiDream / PDRadiopharma at #EANM2025 in Barcelona successfully concluded We shared results from our CA9-targeted theranostic peptide program including first-in-human imaging data. Proud of our team and this exciting step forward in nuclear medicine" [X Link](https://x.com/MasatoMurakami5/status/1975053901650157904) [@MasatoMurakami5](/creator/x/MasatoMurakami5) 2025-10-06T04:21Z XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"We started the development of 64Cu-PSMA-I&T for advanced prostate cancer as part of a registrational trial in Japan. In parallel we are also planning to start a clinical trial for its therapeutic pair 117Lu-PSMA-I&T. Press"
X Link @PeptidreamInc 2025-10-20T04:27Z XX followers, XX engagements
"Ever wondered how much it costs to create a new drug Spoiler alert: its not chump change Dive into the world of peptide drug discovery and see how companies like PeptiDream are gearing up to challenge mega-pharmas globally. Check it out"
X Link @pe65oni 2025-10-17T06:32Z XXX followers, XX engagements
"PeptiDream PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan #biotech #news"
X Link @BCBionetwork 2025-10-15T15:50Z 1481 followers, XX engagements
"🎯 Presentations from PeptiDream / PDRadiopharma at #EANM2025 in Barcelona successfully concluded We shared results from our CA9-targeted theranostic peptide program including first-in-human imaging data. Proud of our team and this exciting step forward in nuclear medicine"
X Link @MasatoMurakami5 2025-10-06T04:21Z XX followers, XXX engagements
/topic/$4587t/posts